Andreas Roller

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.

Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.

Journal: British journal of haematology
Published: October 11, 2013

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Journal: Leukemia
Published: September 19, 2013

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Journal: Leukemia
Published: September 02, 2013

Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease.

Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease.

Journal: Leukemia
Published: July 31, 2013

Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients.

Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients.

Journal: Leukemia
Published: July 18, 2013

Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.

Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.

Journal: Blood
Published: June 25, 2013

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

Journal: Leukemia
Published: May 08, 2013

Landmark analysis of DNMT3A mutations in hematological malignancies.

Landmark analysis of DNMT3A mutations in hematological malignancies.

Journal: Leukemia
Published: March 23, 2013

CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.

CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.

Journal: British journal of haematology
Published: January 07, 2013

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia.

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia.

Journal: Blood cancer journal
Published: September 04, 2012

The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.

The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.

Journal: Genes, chromosomes & cancer
Published: August 28, 2012

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).

Journal: Blood
Published: August 25, 2012
Showing 1-12 of 15

Last Updated: 09/26/2026